EWP-39372-66323
2 vaccinations
3 coded responses
14 check-ins
3 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 46-50
- ZIP prefix
- 956 / CA
- Registered
- 2021-04-09
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-08
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-09
Registered in v-safe
-
2021-04-09
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
- 2021-04-11
- 2021-04-12
- 2021-07-08
- 2021-10-07
-
2021-12-18
Dose 2 — Pfizer-BioNTech
- 2021-12-24
- 2021-12-25
- 2022-01-01
- 2022-01-09
- 2022-01-15
- 2022-01-22
-
2022-01-29
Survey response — day 42, dose 2MedDRA: Fatigue, Feeling of body temperature change, Headache, Migraine, Rhinorrhoea — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: On Tuesday 1/25 I felt extra tired, was hot and cold in the evening, had a migraine the next day along with sniffles. I had a low grade headache on and off since.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-21
Survey response — 3 months, dose 2MedDRA: Abdominal distension, Migraine, Palpitations, Weight increased — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: More migraine headaches, more weight gain and bloating, some heart palpitations.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-21
Report sent to call center — 3 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-03-23
-
2022-03-23
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
-
2022-12-18
Survey response — 12 months, dose 2MedDRA: Brain fog, Dyspnoea, Fatigue, Migraine, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: After my booster in December 2021, my health declined dramatically: severe chronic fatigue, worsening and more frequent migraines, intermittent shortness of breath, brain fog.MedDRA releases: 2024-11 · check-in free text available
-
2022-12-18
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-12-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-08 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-18 | Pfizer-BioNTech | No |
Call center
2 call center cases
1 successful · 1 unsuccessful
Free text
Release 11 — day 42, dose 2
Symptoms: On Tuesday 1/25 I felt extra tired, was hot and cold in the evening, had a migraine the next day along with sniffles. I had a low grade headache on and off since.
Release 11 — 3 months, dose 2
Symptoms: More migraine headaches, more weight gain and bloating, some heart palpitations.
Release 12 — 12 months, dose 2
Symptoms: After my booster in December 2021, my health declined dramatically: severe chronic fatigue, worsening and more frequent migraines, intermittent shortness of breath, brain fog.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal distension | · | · | ✓ |
| SD | Brain fog | · | · | ✓ |
| SD | Dyspnoea | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Feeling of body temperature change | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Migraine | · | · | ✓ |
| SD | Palpitations | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Weight increased | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release